Physiological separation of Alzheimer's disease and Alzheimer's disease with significant levels of cerebrovascular symptomology and healthy controls

被引:11
|
作者
Lithgow, Brian J. [1 ,2 ]
Dastgheib, Zeinab [1 ]
Anssari, Neda [3 ]
Mansouri, Behzad [1 ,3 ]
Blakley, Brian [4 ]
Ashiri, Mehrangiz [1 ]
Moussavi, Zahra [1 ]
机构
[1] Univ Manitoba, Riverview Hlth Ctr, Diagnost & Neurosignal Proc Res Lab, Biomed Engn Program, Winnipeg, MB, Canada
[2] Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia
[3] Brain Vis & Concuss Clin iScope, Vis Matter Res Ins, Winnipeg, MB, Canada
[4] Hlth Sci Ctr, Dept Otolaryngol, Winnipeg, MB, Canada
关键词
Alzheimer's disease; Cerebrovascular symptomatology; Mixed dementia; Vascular dementia; Electrovestibulography; Biomarkers; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; CLINICAL-DIAGNOSIS; NATIONAL INSTITUTE; DEMENTIA; STIMULATION; PERFORMANCE; PROGRESSION; RECEPTORS;
D O I
10.1007/s11517-021-02409-8
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Most dementia patients with a mixed dementia (MxD) diagnosis have a mix of Alzheimer's disease (AD) and vascular dementia. Electrovestibulography (EVestG) records vestibuloacoustic afferent activity. We hypothesize EVestG recordings of AD and MxD patients are different. All patients were assessed with the Montreal cognitive assessment (MoCA) and Hachinski ischemic scale (HIS) (>4 HIS score <7 is representative of MxD cerebrovascular symptomology). EVestG recordings were made from 26 AD, 21 MxD and 44 healthy (control) participants. Features were derived from the EVestG recordings of the average field potential and field potential interval histogram to classify the AD, MxD and control groups. Multivariate analysis was used to test the features' significance. Using a leave-one-out cross-validated linear discriminant analysis with 3 EVestG features yielded accuracies > 80% for separating pairs of AD/MxD/control. Using the MoCA assessment and 2 EVestG features, a best accuracy of 81 to 91% depending on the classifier was obtained for the 3-way identification of AD, MxD and controls. EVestG measures provide a physiological basis for identifying AD from MxD. EVestG measures are hypothesized to be partly related to channelopathies and changes in the descending input to the vestibular periphery. Four of the five AD or MxD versus control features used had significant correlations with the MoCA. This supports assertions that the pathologic changes associated with AD impact the vestibular system and further are suggestive that the postulated physiological changes behind these features have an association with cognitive decline severity.
引用
收藏
页码:1597 / 1610
页数:14
相关论文
共 50 条
  • [1] Physiological separation of Alzheimer’s disease and Alzheimer’s disease with significant levels of cerebrovascular symptomology and healthy controls
    Brian J. Lithgow
    Zeinab Dastgheib
    Neda Anssari
    Behzad Mansouri
    Brian Blakley
    Mehrangiz Ashiri
    Zahra Moussavi
    Medical & Biological Engineering & Computing, 2021, 59 : 1597 - 1610
  • [2] An unbiased algorithm for objective separation of Alzheimer's, Alzheimer's mixed with cerebrovascular symptomology, and healthy controls from one another using electrovestibulography (EVestG)
    Dastgheib, Zeinab A.
    Lithgow, Brian J.
    Moussavi, Zahra K.
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2022, 60 (03) : 797 - 810
  • [3] Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging
    Xia, Ying
    Yassi, Nawaf
    Raniga, Parnesh
    Bourgeat, Pierrick
    Desmond, Patricia
    Doecke, James
    Ames, David
    Laws, Simon M.
    Fowler, Christopher
    Rainey-Smith, Stephanie R.
    Martins, Ralph
    Maruff, Paul
    Villemagne, Victor L.
    Masters, Colin L.
    Rowe, Christopher C.
    Fripp, Jurgen
    Salvado, Olivier
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (01) : 321 - 334
  • [4] An unbiased algorithm for objective separation of Alzheimer’s, Alzheimer’s mixed with cerebrovascular symptomology, and healthy controls from one another using electrovestibulography (EVestG)
    Zeinab A. Dastgheib
    Brian J. Lithgow
    Zahra K. Moussavi
    Medical & Biological Engineering & Computing, 2022, 60 : 797 - 810
  • [5] Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
    Barnes, Josephine
    Carmichael, Owen T.
    Leung, Kelvin K.
    Schwarz, Christopher
    Ridgway, Gerard R.
    Bartlett, Jonathan W.
    Malone, Ian B.
    Schott, Jonathan M.
    Rossor, Martin N.
    Biessels, Geert Jan
    DeCarli, Charlie
    Fox, Nick C.
    NEUROBIOLOGY OF AGING, 2013, 34 (08) : 1996 - 2002
  • [6] Cerebrovascular disease in ageing and Alzheimer's disease
    Love, Seth
    Miners, J. Scott
    ACTA NEUROPATHOLOGICA, 2016, 131 (05) : 645 - 658
  • [7] Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region
    Chen, C.
    Homma, A.
    Mok, V. C. T.
    Krishnamoorthy, E.
    Alladi, S.
    Meguro, K.
    Abe, K.
    Dominguez, J.
    Marasigan, S.
    Kandiah, N.
    Kim, S. Y.
    Lee, D. Y.
    De Silva, H. A.
    Yang, Y. -H.
    Pai, M. -C.
    Senanarong, V.
    Dash, A.
    JOURNAL OF INTERNAL MEDICINE, 2016, 280 (04) : 359 - 374
  • [8] Mixed dementia: Alzheimer's and cerebrovascular disease
    Rockwood, K
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 39 - 46
  • [9] Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease
    Yassi, Nawaf
    Hilal, Saima
    Xia, Ying
    Lim, Yen Ying
    Watson, Rosie
    Kuijf, Hugo
    Fowler, Christopher
    Yates, Paul
    Maruff, Paul
    Martins, Ralph
    Ames, David
    Chen, Christopher
    Rowe, Christopher C.
    Villemagne, Victor L.
    Salvado, Olivier
    Desmond, Patricia M.
    Masters, Colin L.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (03) : 897 - 907
  • [10] Emerging Concepts in Alzheimer's Disease
    Vinters, Harry V.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10, 2015, 10 : 291 - 319